FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * MOORE JOHN A   2. Issuer Name and Ticker or Trading Symbol ELITE PHARMACEUTICALS INC /DE/ [ELI] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O EDSON MOORE HEALTHCARE VENTURES, INC, 101 BROOKMEADOW ROAD 3. Date of Earliest Transaction (Month/Day/Year) 01/21/2005 (Street) WILMINGTON, DE 19807 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 01/24/2005   S   10,000 D $ 4.14 53,000 (1) D   Common Stock 01/21/2005   S   25,000 D $ 4.2697 53,000 (1) D   Common Stock 01/21/2005   S   25,000 D $ 4.3053 53,000 (1) D   Common Stock 01/21/2005   S   32,109 D $ 4.35 53,000 (1) D   Common Stock 01/21/2005   S   50,000 D $ 4.32 53,000 (1) D   Common Stock 01/21/2005   S   125,000 D $ 4.3 53,000 (1) D   Common Stock 01/21/2005   S   25,000 D $ 4.27 53,000 (1) D   Common Stock 01/21/2005   S   40,000 D $ 4.25 53,000 (1) D   Common Stock 01/21/2005   S   25,000 D $ 4.2588 53,000 (1) D   Common Stock 01/21/2005   S   10,000 D $ 4.2145 53,000 (1) D   Common Stock 01/21/2005   S   10,000 D $ 4.2116 53,000 (1) D   Common Stock 01/21/2005   S   10,000 D $ 4.23 53,000 (1) D   Common Stock 01/21/2005   S   5,000 D $ 4.22 53,000 (1) D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
MOORE JOHN A C/O EDSON MOORE HEALTHCARE VENTURES, INC 101 BROOKMEADOW ROAD WILMINGTON, DE 19807	X

Signatures

John A. Moore		01/21/2005
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The Reporting Person Beneficially owns 43,000 shares of Common Stock directly and 10,000 shares of Common Stock indirectly. The 10,000 shares of Common Stock are directly owned by Edson Moore Healthcare Ventures, Inc., a Delaware corporation ("EMC"), of which the Reporting Person owns 50%. Also, this amount does not include (i) 360,000 options previously granted to the Reporting Person nor (ii) a warrant to purchase 100,000 shares of Common Stock of the Issuer held by EMC. The Reporting Person acknowledges his obligations to pay to the Issuer the difference between (i) the highest aggregate proceeds from the sale of 19,900 shares during the six month period ending April 4, 2005 and $24,624.26 and (ii) the highest aggregate gross proceeds from the sale of 8,100 shares during the six month period ended April 1, 2005 and $9,705.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.